Evidence map›Paper›PMID 38426075›Full record

ArticleFood chemistry: X2024

Fabrication of diosmin loaded food-grade bilayer nanoparticles with modified chitosan and soy peptides and antioxidant properties examination.

Sen Li, Tong Guan, Hongyan Lv, Yuwei Cai, Wanqing Cao, Ze Zhang, Hongdong Song, Hongwei Cao, Xiao Guan

Open access · goldAbstract read
In one paragraph

Article in Food chemistry: X, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sen LiSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Tong GuanSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Hongyan LvSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Yuwei CaiSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Wanqing CaoSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Ze ZhangSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Hongdong SongSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Hongwei CaoSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Xiao GuanSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
University of Shanghai for Science and Technology · CNAcademy of State Administration of Grain · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diosmin is a flavonoid derived from plants, possessing anti-inflammatory, antioxidant, antidiabetic, neuroprotective and cardiovascular protective properties. However, diosmin has low solubility in water, leading to low bioavailability. In this study, we constructed bilayer nanoparticles with trimethyl chitosan and soy peptides to improve the oral bioaccessibility and bioavailability of diosmin, and determined the characteristics and antioxidant properties of the diosmin-loaded nanoparticles. The results showed that the size of the nanoparticles was around 250 nm with the encapsulation efficiency higher than 97 %, and the nanoparticles were stable under regular conditions.

Indexed as

Antioxidant activityDiosminNanoparticlesSoy peptidesTrimethyl chitosan

Identifiers

PMID38426075
PMCPMC10902142
OpenAlexW4391920206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.